Drug Profile
BB 10010
Alternative Names: Macrophage inflammatory protein-1-alpha analogue; MIP-1alpha variant; NagrestipLatest Information Update: 07 May 2003
Price :
$50
*
At a glance
- Originator British Biotech
- Class Radioprotectives
- Mechanism of Action Immunosuppressants; Mitosis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Chemotherapy-induced damage; HIV infections; Myeloid leukaemia; Radiation injuries